Herpes Zoster
📧 Sign up to get email alerts when something new happens for Herpes Zoster.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-03-15FDA Approved: ACYCLOVIR — Original Application (Viona Pharmaceuticals Inc)
FDA approved the generic acyclovir product from Viona Pharmaceuticals Inc under an Original Application.
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013) [Phase 1]
Phase 1 study evaluating safety and immunogenicity of an inactivated varicella-zoster vaccine in adults with hematologic malignancies receiv…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates [NA]
A completed clinical trial evaluated the use of an electronic medical record in primary care to improve herpes zoster vaccination rates, wit…
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009) [Phase 2]
Phase 2 clinical trial assessing safety and immunogenicity of an inactivated Varicella Zoster Virus vaccine in adults with autoimmune diseas…
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects [Phase 2]
Phase 2 trial assessing safety and immunogenicity of the zoster vaccine GSK1437173A in elderly subjects has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Month 30 & 42 Extension Studies of CRD-004 Primary Study [Phase 2]
Extension studies for CRD-004 in herpes zoster completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: Dose-finding Study of ASP2151 in Subjects With Herpes Zoster [Phase 2]
Phase 2 dose-finding study of ASP2151 in subjects with herpes zoster has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-18Clinical Trial Update: Phase III Study of ASP2151 in Herpes Zoster Patients [Phase 3]
Phase III study of ASP2151 in herpes zoster has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age [Phase 3]
Phase 3 trial evaluating the impact of reactogenicity on quality of life after administration of GSK's HZ/su vaccine (GSK1437173A) in adults…
-
FDA approval · 2018-08-31FDA Approved: ACYCLOVIR — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original application for acyclovir from Zydus Pharmaceuticals (USA) Inc., enabling a generic version of acyclovir.
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy [Phase 3]
Phase 3 trial update on immunogenicity and safety of GSK's Herpes Zoster vaccine in adults with solid tumors receiving chemotherapy; study c…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Acupuncture in Herpes Zoster Neuralgia (ACUZoster) [Phase 4]
Phase 4 clinical trial update assessing acupuncture for herpes zoster neuralgia and postherpetic neuralgia has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant [Phase 3]
Phase 3 trial assessing immunogenicity and safety of GSK's HZ/su vaccine in adults 18+ with renal transplant; completed with results posted …
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001) [Phase 3]
Phase 3 trial evaluating an inactivated varicella-zoster vaccine for prevention of herpes zoster and related complications in hematopoietic …
-
CLINICAL_TRIALS research · 2018-06-01Clinical Trial Update: A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above
This completed study sponsored by GlaxoSmithKline assessed the burden of herpes zoster (and postherpetic neuralgia) in Japanese adults aged …
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Herpes Zoster Vaccine for Bone Marrow Transplant Donors [Phase 2]
Phase 2 clinical trial evaluating a herpes zoster vaccine for bone marrow donor vaccination has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN). [Phase 2]
Phase 2 trial update reports effectiveness and safety findings for carisbamate (RWJ-333369) in postherpetic neuralgia, with the study comple…
-
CLINICAL_TRIALS trial_result · 2018-04-24Clinical Trial Update: Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of GlaxoSmithKline's herpes zoster subunit vaccine (Shingrix) when co-administered wi…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011) [Phase 3]
Phase 3 trial evaluating the safety and efficacy of the inactivated varicella-zoster vaccine for preventing herpes zoster and related compli…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors [Phase 4]
Phase 4 trial evaluating ZOSTAVAX in patients about to start chemotherapy for solid organ tumors; results were posted in 2018.
-
FDA approval · 2018-04-06FDA Approved: ACYCLOVIR — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals Inc.'s original ANDA for acyclovir, granting a generic version of the antiviral for herpes simplex infe…
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection [NA]
A completed Mayo Clinic-sponsored trial evaluating scrambler therapy for chronic pain in patients with a rash due to Varicella Zoster virus …
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults [Phase 1]
Phase 1 trial update showing safety and immunogenicity of GlaxoSmithKline's Herpes Zoster Vaccine 1437173A in healthy ethnic Japanese adults…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A [Phase 3]
Phase 3 trial update for GSK's herpes zoster vaccine GSK1437173A shows completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-22Clinical Trial Update: Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043) [Phase 3]
Phase 3 trial comparing a 1-dose zoster vaccine regimen to various 2-dose regimens in adults 70 and older; study completed with results post…